Course 0 · Lesson 1 · Public

A paper is not a protocol

A study is a bounded report. It is not a plan for a person, a vial, or a use it did not test. This site grades evidence by what kind of object it is, not by whether something is “safe.”

18+ · No peptide sales · No medical advice

From Course 0, How to read peptide evidence

1. State the claim as a claim

The move this lesson is about:

“This study found X. Therefore do X.”

That second sentence is a claim. It is not in the paper. The paper reported a result under its own conditions. The second sentence adds a person, a product, a use, and a plan the paper did not contain.

Name the parts before you read further:

• What effect is being claimed.
• In whom, or in what system, the paper actually looked.
• In what product, preparation, or analog.
• For what use.
• What the reader is being invited to do with that.

If you cannot name those parts, you do not have a claim yet. You have a headline.

Some peptides exist as approved medicines for a labeled use. Many names in circulation are investigational and have no approved indication. That split matters later. It does not turn either category into a protocol.

This site does not tell you what to take, how to take it, or where to get it. It teaches you not to let a PDF do that job either.

2. What a paper is, and is not

A paper is a report of a specific attempt. Methods, subjects or systems, materials, outcomes, time window, limitations. That is the object.

A paper is not:

• A protocol for you.
• Proof that a vial in the world is the material in the methods section.
• A finding that generalizes to every analog, every preparation, every route, every use.
• A safety rating for a person.
• An instruction to start, stop, or change anything.

What would confirm a claim

The claim is confirmed only if further work tests the same claim, not a neighbor of it: the relevant species, the relevant product, the relevant use, the outcome actually named, with the obvious other explanations controlled. Independent replication is stronger than a single paper restated in a forum post. Confirmation is about the claim you stated in section 1, not a warmer feeling about the topic.

What would disconfirm a claim

The effect does not show up when the claim is tested more directly. The result depends on a species, a cell system, or an outcome that is not the one being claimed. The apparent effect disappears when concurrent changes, expectation, or product identity are handled. The paper’s material is not the product under discussion. A limitation the authors listed is doing the work that the headline is not allowed to do.

“This study found X” is a statement about that study. “Do X” is a different statement. The gap between them is the lesson.

3. How papers get turned into fake protocols

Four substitutions do most of the damage. They are not rare. They are the default if you do not mark them.

Product identity

The vial is not the molecule in the paper. A named sequence in a methods section is not a finished product. An approved medicine is not a compounded copy, a research vial, or a similarly named analog. If the paper used a specific product, a specific manufacturer’s material, or a specific preparation, that is part of the result. Strip it out and you are no longer talking about the paper. You are talking about a different object that borrowed the paper’s authority.

Concurrent changes

People rarely change one thing. Training, food, sleep, other medicines, stopping something else, getting less sick, getting more attention. A paper that does not account for those is not a license to ignore them in a personal record either. If several things moved, the paper did not tell you which one did the work. Neither did the anecdote.

Placebo, expectation, and regression

Some of what looks like an effect is the course of the problem, the decision to measure, or the belief that a change was made. Controlled trials exist because this is ordinary, not because researchers are pedants. An uncontrolled series, a before/after story, or an open-label report has not removed it. That does not make the report worthless. It makes it a report, not a protocol.

Indication vs this use vs this product

Approval is not a property of a molecule in the abstract. It is a property of a specific product, for a specific use, in a specific population, under a specific label. A labeled indication does not travel to another use. It does not travel to another product with a related name. An investigational compound with no approved indication has no label to borrow. “Approved for something” is not “approved for this.” “Discussed for this” is not “established for this.”

These four are enough to stop most paper-to-plan copies. Course 0 continues them. This lesson only needs you to see the copy happening.

4. Evidence grades this site uses

These marks are kinds of object. They are not a traffic light. They are not safe / caution / unsafe. A higher-sounding grade does not mean you should do something. A lower-sounding grade does not mean you should not. They tell you what you are looking at.

• Anecdote
• Preclinical
• Early human
• Approved indication
• Off-label discussion

Kind of evidence. Not a safety rating.

Anecdote

A labeled personal report. What one person noticed, under conditions they may or may not have recorded. On this site, that includes firsthand member reports once they are labeled as reports. An anecdote can generate a question. It cannot confirm a general effect. It cannot stand in for a paper, and a paper cannot be demoted into “just an anecdote” to avoid its actual methods. Different object.

Preclinical

Cells, tissues, animals, in vitro systems. Useful for mechanism and for generating a human question. It does not establish that the same thing happens in a person. It does not establish that a human product matching the paper exists. Animal effect is not human effect. A pathway in a dish is not an outcome in a body.

Early human

Humans were involved: case reports, case series, small or uncontrolled studies, early-phase work. That is not the same as an adequate test of the claim you care about. Sample, control, duration, outcome, and product still have to match the claim. “There is a human paper” is not “the claim is settled.”

Approved indication

A regulator has approved a specific product for a specific use in a specific population, with a specific label. On this site’s compound pages, that fact is currently discussed in FDA terms. The grade is about that product–use pair. It is not a general clearance of the molecule. It is not a clearance of other products, other preparations, or other uses. It is not a statement that the medicine is appropriate for a given person. That last question belongs to a clinician and a label, not to this page.

Off-label discussion

Talk about a use that is not the labeled indication, including when an approved medicine is being discussed for something else. Off-label is a regulatory position of a use, not a second approval and not a proof. This grade does not apply to compounds that have no approved indication at all; those sit in anecdote, preclinical, or early human, depending on what you are actually looking at. Discussion of an off-label use is not evidence that the use is established.

How to use the marks: pick the one that names the object in front of you. If a post mixes a rodent paper, a labeled medicine, and a personal story, that is three objects. Grade them separately. Do not average them into a glow.

5. Questions to take, not a plan to follow

Use these on a paper, a post, or in a conversation with a licensed clinician. They are questions. They are not a protocol, a dose, a schedule, or a source.

1. What exact claim is being made: effect, population or system, product, use?
2. Which of this site’s five grades names that object?
3. What would confirm this claim? What would disconfirm it?
4. Is the product in the paper the same object as the product being discussed?
5. What else moved at the same time?
6. If anything is approved, what is the labeled indication, for which product, and is this that indication?
7. What did the authors list as a limitation that the headline ignored?

If a sentence answers these by telling you what to use, how much, how often, how to mix it, or where to get it, it has left the lesson. That sentence does not belong here, and it does not belong in a paper’s margin as if the authors wrote it.

Self-check

Ungraded. Reveal each answer after you attempt the question. No certificate.

1. “This study found X. Therefore do X.” Which sentence is in the paper, and which one is a claim someone added?

Answer: Only the first is about the paper. The second is a claim. It adds a person, a product, a use, and a plan the paper did not contain.

2. Before a claim counts as a claim, what five parts should you be able to name?

Answer: The effect claimed, in whom or in what system the paper looked, in what product, preparation, or analog, for what use, and what the reader is being invited to do. If you can’t name them, you have a headline, not a claim.

3. True or false: a paper that used a specific preparation also supports a vial with the same name on the label.

Answer: False. The vial is not the molecule in the paper. Product identity is part of the result. Take it out and you are talking about a different object that borrowed the paper’s authority.

4. A medicine is approved for one use. Someone discusses it for a different use. Which grade names that discussion, and does the approval carry over?

Answer: Off-label discussion. The approval does not carry over. A labeled indication belongs to a specific product, use, population, and label. “Approved for something” is not “approved for this.”

5. A post cites a rodent paper, mentions a labeled medicine, and adds a personal story. How many grades apply, and how do you combine them?

Answer: Three objects: preclinical, approved indication, and anecdote. Grade each one separately. Don’t combine them into one overall impression.

6. True or false: “Early human” means the claim is settled because people were studied.

Answer: False. Early human work shows that humans were involved. It is not yet an adequate test of the claim unless the sample, control, duration, outcome, and product match that claim.

Log in or join to track your progress.Self-check is open to all. Progress tracking needs an account.

Close: Lesson 2 takes up approval, compounding, and “research use only” as different objects. This lesson has one job: stop copying a paper into a plan.